Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-13-000522
Filing Date
2013-05-09
Accepted
2013-05-09 19:51:10
Documents
1
Period of Report
2013-05-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6123
  Complete submission text file 0000904454-13-000522.txt   7531
Mailing Address 4105 E MADISON STREET SUITE 320 SEATTLE WA 98112
Business Address 4105 E MADISON STREET SUITE 320 SEATTLE WA 98112 206 325 6086
ATOSSA GENETICS INC (Issuer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O ATOSSA GENETICS, INC. 4105 MADISON STREET, SUITE 320 SEATTLE WA 98112
Business Address
Galli Stephen J (Reporting) CIK: 0001551951 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35610 | Film No.: 13830745